LAB
Standard BioTools Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website andardbio.com
- Employees(FY) 523
- ISIN US34385P1084
Performance
+6.64%
1W
-5.17%
1M
0.0%
3M
+16.82%
6M
+16.29%
YTD
+31.79%
1Y
Profile
Standard BioTools Inc., together with its subsidiaries, creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc; and collaboration agreement with Navignostics AG for development using the Hyperion XTi Imaging System. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.
Investment Analysis Report: LAB
Overview
LAB is a company operating in the Health Technology sector, specifically in the Medical Specialties industry. In this report, we will conduct a detailed investment analysis of LAB focusing on various perspectives including Valuation, Financial Health, Earnings and Revenue Growth, Profitability, Operating ...
Technical Analysis of LAB 2024-05-10
Overview:
In analyzing the technical indicators for LAB stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to...
Recent News & Updates
- 2024-05-13 10:45
- 2024-05-12 22:45
- 2024-05-08 16:33
Standard BioTools: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-08 16:01
- 2024-05-08 08:59
- 2024-05-08 04:01
- 2024-04-25 11:27
- 2024-04-25 08:01
- 2024-04-25 08:00
- 2024-04-24 20:01
- 2024-04-24 20:00
- 2024-04-16 07:37
Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic?(Simply Wall St.)
- 2024-04-08 08:00
- 2024-04-07 20:00
- 2024-04-03 16:01
- 2024-04-03 04:01
- 2024-04-02 06:54
- 2024-03-19 06:02
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)(Simply Wall St.)
- 2024-03-18 08:12
- 2024-03-17 20:12
- 2024-03-07 06:32
Daily – Vickers Top Buyers & Sellers for 03/07/2024(Argus Research)
- 2024-03-05 08:27
- 2024-03-01 05:57
- 2024-02-29 06:29
Q4 2023 Standard BioTools Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-02-28 16:41
- 2024-02-28 16:16
Standard BioTools: Q4 Earnings Snapshot(Associated Press Finance)
- 2024-02-28 16:01
- 2024-02-28 03:01
- 2024-02-26 08:00
- 2024-02-25 19:00
Page 1 of 5
previousnext